Current position:Home >Product >
6,6,9-trimethyl-3-(3-methyloctan-2-yl)-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
6,6,9-trimethyl-3-(3-methyloctan-2-yl)-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(22972-69-6)
- Name: 6,6,9-trimethyl-3-(3-methyloctan-2-yl)-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
- Synonyms:(1'',2''-Dimethyl-5''-ethyl)-D1-THC; NSC 86933
- Molecular Formula:C25H38 O2
- Molecular Weight:370.568
- CAS Registry Number:22972-69-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.22972-69-6 6H-Dibenzo[b,d]pyran-1-ol,3-(1,2-dimethylheptyl)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]
CAS No.22972-69-6 22972-69-6 6H-Dibenzo[b,d]pyran-1-ol,3-(1,2-dimethylheptyl)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-
Assay:99% Appearance:white powder Package:as clients needs Storage:RT Transportation:SEA Application:Organic Chemicals
Min. Order:1Kilogram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]

Other Product
- 86527-20-0/9-(6'-deoxytalofuranosyl)hypoxanthine
- 51837-53-7/7-[(2Z)-1-hydroxy-2-(2-oxo-5-phenyl-2,3-dihydro-7H-1,4-benzodiazepin-7-ylidene)hydrazinyl]-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
- 6941-03-3/4-chloro-6-[2-(3,4-dichlorophenyl)ethyl]pyrimidin-2-amine
- 73826-35-4/1-(4-azetidin-2-ylphenyl)-3-piperidin-1-ylpropan-1-one hydrochloride
- 84962-76-5/2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane
- 134267-49-5/20-ethyl-3,13,15-trihydroxy-1,6,16-trimethoxy-4-(methoxymethyl)-8-[(9E,12E)-octadeca-9,12-dienoyloxy]aconitan-14-yl 4-methoxybenzoate
- 72990-10-4/(E)-1-(3-methylpyridin-4-yl)-N-propoxymethanimine hydrochloride (1:1)
- 76337-94-5/2-amino-N-{[{4-chloro-2-[(2-chlorophenyl)carbonyl]phenyl}(methyl)amino]acetyl}-N-(2-phenylethyl)acetamide ethanedioate
- 85966-69-4/phenyl hexylcarbamate
- 5006-83-7/1-(3,4-dichlorophenyl)-3-propylurea
- 29011-83-4/Diethylene glycol, neopentyl glycol, isophthalic acid, maleic anhydride polymer
- 4266-46-0/16β-Acetoxy-14-hydroxy-3-oxo-5β,14β-bufa-20,22-dienolide
- 31386-90-0/Vanadium,[[2,2',2''-nitrilotris[ethanolato]](3-)-N,O,O',O'']- (9CI)
- 1453-82-3/Isonicotinamide
- 39391-78-1/L Ag25
- 5149-33-7/2-(7-methoxybenzofuran-2-yl)-8-methyl-quinoline-4-carboxylic acid
- 22972-69-6/6,6,9-trimethyl-3-(3-methyloctan-2-yl)-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
- 60008-03-9/GLABRENE
- 20460-41-7/(8ξ,9ξ,10ξ,11ξ,12ξ,13ξ,14ξ)-2-(Tetrahydro-4-methyl-5-oxofuran-2-yl)stenine
- 1726-85-8/4-(methylsulfanyl)cinnoline
- 139605-52-0/8-chloro-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1H)-one
- 73832-16-3/N-[2-(fluoromethyl)-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-6-yl]formamide
- 100482-46-0/2-({3-[4-(phenoxymethyl)phenyl]propyl}amino)butan-1-ol
- 8061-58-3/thyroxine - triiodothyronine combination
- 68988-92-1/Wright's stain
- 147627-01-8/RNA formation factor(mouse clone 11R5/11 gene ALF1 isoform A reduced) (9CI)
- 68095-47-6/2-nitro-5-{2-phenyl-1-[(trichloromethyl)sulfonyl]ethenyl}furan
- 40226-25-3/N-[(2-Chloro-1-naphthalenyl)methylene]-2-methoxybenzenamine
- 3786-08-1/N-ACETYL-L-PHENYLALANYL-3,5-DIIODO-L-TYROSINE
- 122113-24-0/6H-Pyrrolo[2,3-d]pyrimidin-6-one,2-[1,4'-bipiperidin]-1'-yl-5,7-dihydro-7-methyl-, hydrochloride (1:1)